Advertisment

Understanding CAR-T Cell Therapy: Insights, Eligibility, and Side Effects

author-image
Mason Walker
New Update
NULL

Understanding CAR-T Cell Therapy: Insights, Eligibility, and Side Effects

Advertisment

According to Dr. Mohamed Kharfan Dabaja from Mayo Cancer Care, Chimeric Antigen Receptor T-cell (CAR-T) therapy is providing a beacon of hope for cancer patients worldwide. This innovative therapy uses the patient's own immune system to combat certain blood cancers, including some forms of non-Hodgkin lymphoma and a certain type of leukemia. However, an understanding of its process, eligibility criteria, and potential side effects is crucial for informed decision-making.

Advertisment

What is CAR-T Cell Therapy?

CAR-T cell therapy is a type of immunotherapy that uses the body's own immune system to fight cancer. The treatment involves collecting T cells (a type of white blood cell) from the patient, modifying them in a lab to recognize and target cancer cells, multiplying these altered cells, and then infusing them back into the patient's bloodstream. This therapy has revolutionized cancer treatment, with several CAR T cells targeting specific antigens on cancer cells and gaining FDA approval, such as those targeting CD19 and BCMA. It constitutes a crucial weapon in the fight against hematological malignancies and has shown tremendous efficacy in treating patients with multiple myeloma.

Eligibility for CAR-T Cell Therapy

Advertisment

Not all cancer patients are eligible for CAR-T cell therapy. The criteria for eligibility primarily depend on the type and stage of the cancer, the patient's overall health status, and the specific CAR-T therapy being considered. This therapy is usually reserved for patients with aggressive or refractory cancers that have not responded to other treatments. Health insurers are still in the process of defining their coverage policies for this innovative treatment.

The Treatment Process

Centers like the Huntsman Cancer Institute and St George’s Hospital are among the few healthcare institutes that offer CAR-T cell therapy. The treatment process requires a significant time commitment from patients and their families. After the T cells are collected and modified, they are infused back into the patient's body. Following the treatment, patients are required to stay within 40 miles, or sixty minutes, of the treatment center for 30 days to monitor their progress and manage any side effects. To accommodate this requirement, some institutes offer nearby housing for patients and their families.

Advertisment

Potential Side Effects

While this therapy offers substantial hope for patients with limited treatment options, it is not without its potential side effects. These can range from mild to severe and may include symptoms like fever, fatigue, difficulty breathing, confusion, and changes in blood pressure. In some cases, the therapy may cause cytokine release syndrome (CRS), a severe inflammatory response. Despite these side effects, the response rate to CAR-T cell therapy is highly encouraging, with about 50 to 70 per cent of patients showing positive responses.

As the medical field continues to evolve, CAR-T cell therapy is being recognized as a revolutionary treatment that offers renewed hope for cancer patients. However, it's essential for patients and their families to understand the treatment process thoroughly and discuss potential risks and benefits with their healthcare providers before making a decision.

Advertisment
Chat with Dr. Medriva !